http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004532868-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08 |
| filingDate | 2002-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004532868-A |
| titleOfInvention | Use of azetidinone-substituted derivatives in the treatment of Alzheimer's disease |
| abstract | Provided are methods of preventing, treating, or ameliorating Alzheimer's disease, modulating the production or level of amyloid β (Aβ) peptide, and / or regulating the amount of ApoE isoform 4 in the bloodstream and / or brain; The method comprises administering to a subject in need of such treatment at least one compound represented by Formula (IX) disclosed herein, or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable salt thereof. Administering an effective amount of a composition containing a solvate. |
| priorityDate | 2001-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 482.